• Cat-intel
  • MedIntelliX
  • Resources
  • About Us
  • Request Free Sample ×

    Kindly complete the form below to receive a free sample of this Report

    Leading companies partner with us for data-driven Insights

    clients tt-cursor
    Hero Background

    EMEA Cardiac Valve market

    ID: MRFR/MED/0167-HCR
    80 Pages
    Rahul Gotadki
    October 2025

    EMEA Cardiac Valve Market Growth And Application By Types (Trans-Catheter Heart Valve, Tissue Heart Valve, And Mechanical Heart Valve, And Others), By Diseases (Aortic Valve Replacement, Heart Valve Disease, Mitral Valve Stenosis, And Others), By Treatment (Valve Replacement, Valve Repair, And Others), And By End Users (Cardiac Research Institute, Hospital & Clinics, And Others) - Forecast Till 2035

    Share:
    Download PDF ×

    We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

    Purchase Options

    EMEA Cardiac Valve market Summary

    Market Segment Insights

    The EMEA cardiac valve market is segmented on the basis of types, by diseases, by treatment, and by end users.

    EMEA Cardiac Valve Types Insights

    On the basis of types the market is segmented into trans-catheter heart valve, tissue heart valve, and mechanical heart valve, others.

    EMEA Cardiac Valve Disease Insights

    On the basis of disease, the market is segmented into aortic valve replacement, heart valve disease, mitral valve stenosis, and others.

    EMEA Cardiac Valve Treatments Insights

    On the basis of treatments, it is segmented into valve replacement, valve repair, and others.

    EMEA Cardiac Valve End Users Insights

    On the basis of end users, the markets segmented into cardiac research institute, hospital & clinics, and others.

    Industry Developments

    Central parts in the Cardiac Valve Market are centered around item endorsement and send-off to extend their item portfolio. For example, in November 2019, Edwards Lifesciences Corporation got CE Mark for Edwards SAPIEN 3 transcatheter heart valve for the treatment of patients determined to have aortic stenosis who are generally safe for an open-heart medical procedure.

    In April 2019, Boston Scientific Corporation got U.S. Food and Drug Administration (FDA) endorsement for the LOTUS Edge Aortic Valve System.

    EMEA Cardiac Valve Market Report Overview:

    This report means to give experiences into the worldwide prosthetic heart valve market. It gives significant data on the sorts of valves and areas in the fake heart valve market. Driving players in the Cardiac Valve Market are profiled to concentrate on their item contributions and comprehend the techniques attempted by them to be serious in this market.

    The previously mentioned data would help the purchaser by assisting them with getting the market elements. Furthermore, the estimates given in the report will empower firms to comprehend the patterns in this market and better position themselves to underwrite useful learning experiences.

      • To characterize, portray, and conjecture the prosthetic heart valve market based on sort of valve and area.
      • To give point by point data in regards to the main considerations affecting the development of the market (drivers, restrictions, open doors, and difficulties)
      • To decisively break down the micro Cardiac Valve Market regarding individual development patterns, possibilities, and commitments to the general market.
      • To dissect the potential open doors on the lookout for partners and give subtleties of the cutthroat scene for market pioneers.
      • To gauge the income of the Cardiac Valve Market fragments concerning four principle provincial portions, to be specific, North America, Europe, Asia-Pacific, and the Rest of the World (RoW)
      • To profile the vital participants and thoroughly examine their portions of the overall industry and center abilities as far as market improvement and development techniques.
      • To follow and break down cutthroat improvements, for example, showcasing and limited time exercises, endorsements, item dispatches, acquisitions, arrangements, joint efforts, extensions, affirmations, and repayment endorsements in the prosthetic heart valve.

    Market Segmentation

    EMEA Cardiac Valve Type Outlook

    • Transcatheter Heart Valve
    • Tissue Heart Valve
    • Mechanical Heart Valve

    EMEA Cardiac Valve Regional Outlook

    North America
    • The U.S.
    • Canada
    Europe
    • Germany
    • France
    • The U.K.
    • Rest of Europe (RoE)
    Asia-Pacific
    • Japan
    • China
    • India
    • Rest of Asia-Pacific (RoAPAC)

    Report Scope

    Attribute/Metric Details
    Market Size 2030  USD 17.5 Billion 2032
    Compound Annual Growth Rate (CAGR) 10.45% 2032
    Base Year 2023
    Market Forecast Period 2024-2032
    Historical Data 2018 - 2022
    Market Forecast Units Value (USD Billion)
    Report Coverage Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
    Segments Covered Product, technology, application, and end-users.
    Geographies Covered Americas, Europe, Asia Pacific and the Middle East and Africa
    Countries Covered China, Japan, India, Australia, South Korea, Australia, Rest of Asia-Pacific
    Key Companies Profiled Cardiac Valve Market incorporate Edwards Lifesciences Corporation, Medtronic plc., Boston Scientific Corporation, Abbott Laboratories, LivaNova PLC, CryoLife, Inc., BraileBiomedica, Colibri Heart Valve, LLC, and JenaValve Technology, Inc.
    Key Market Opportunities Growing prevalence of cardiovascular diseases globally presents significant opportunities for innovation and expansion in the cardiac valve market.
    Key Market Dynamics Increasing prevalence of age-related cardiac conditions drives demand.

    Market Highlights

    Author
    Rahul Gotadki
    Assistant Manager

    He holds an experience of about 7+ years in Market Research and Business Consulting, working under the spectrum of Life Sciences and Healthcare domains. Rahul conceptualizes and implements a scalable business strategy and provides strategic leadership to the clients. His expertise lies in market estimation, competitive intelligence, pipeline analysis, customer assessment, etc. In addition to the above, his other responsibility includes strategic tracking of high growth markets & advising clients on the potential areas of focus they could direct their business initiatives

    Leave a Comment

    FAQs

    What is the projected EMEA Cardiac Valve Market valuation during the forecast period of 2024-2032?

    The projected CAGR would be 10.45% during the forecast period of 2024-2032.

    What could prevent the EMEA Cardiac Valve Market growth?

    High cost associated with it could hamper the EMEA Cardiac Valve Market prospect.

    Who are the end users analyzed in the EMEA Cardiac Valve Market?

    The end users are a cardiac research institute, hospital & clinics, and others.

    What are the treatments discussed in the EMEA Cardiac Valve Market?

    The treatments are valve repair, valve replacement, and others.

    Name the diseases involved in the EMEA Cardiac Valve Market report.

    The diseases named in the report are mitral valve stenosis, heart valve disease, aortic valve replacement, and others.

    Download Free Sample

    Kindly complete the form below to receive a free sample of this Report

    Case Study
    Chemicals and Materials